- Service Name
Repligen Bioprocessing Solutions
- Industry
Biotechnology, Biopharmaceuticals, Bioprocessing, Life Sciences
- Main Value Proposition
Repligen provides innovative bioprocessing technologies that enhance productivity and simplify complex workflows in the manufacture of biologic drugs.
- Description
Repligen develops consumable products and technologies for the manufacture of biological drugs, focusing on bioprocessing advancements. Their solutions enhance productivity and efficiency in the production of biologics, including plasmid DNA, viral vectors, and mRNA.
- Key Features
First bench scale TFF system built for cGMP production; CTech™ SoloVPE® PLUS System for accurate UV-Vis concentration measurement; Holder-free, self-contained TFF device (TangenX® SC); Real-time Process Management Solutions
- Use Cases
Manufacturing of plasmid DNA and viral vectors; Real-time concentration measurement in downstream processes; Process development and scale-up for biologics production
- Competitive advantages
Proven scaling from 1 L to 5000 L in commercial processes; Comprehensive product range including single-use solutions and advanced analytics; Strong partnerships and acquisitions that enhance product offerings and market reach
- Strengths
Repligen's strengths lie in its innovative product development, extensive application data, and a strong commitment to meeting regulatory GMP requirements.
- Positioning
Repligen positions itself as a leader in bioprocessing technology, emphasizing innovation and efficiency in the production of biologics.
- Audience
The primary audience includes biopharmaceutical manufacturers, process engineers, and researchers in the life sciences sector who require advanced bioprocessing solutions.
- CTA
Find a better way
- Tags
Bioprocessing
Biologics
Process Intensification
Single-use Solutions
- Tagline
INNOVATE. INTENSIFY. EXPAND.
- Tone of Voice
Innovative, Professional, Trustworthy
- Differentiation
Repligen stands out in the market with its focus on process intensification and the development of unique, first-to-market technologies that cater specifically to the needs of biopharmaceutical manufacturers.
- Brand Positioning
Repligen's brand identity is centered around being a trusted partner in bioprocessing, dedicated to improving human health through advanced technology.
- Founded
1981-01-01
- Founders
Paul Schimmel